• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单胺氧化酶导致瓣叶氧化应激:严重二尖瓣反流患者的前瞻性观察性初步研究。

Monoamine Oxidase Contributes to Valvular Oxidative Stress: A Prospective Observational Pilot Study in Patients with Severe Mitral Regurgitation.

机构信息

Department VI-Cardiology, "Victor Babeș" University of Medicine and Pharmacy of Timișoara, E. Murgu Sq. no 2, 300041 Timișoara, Romania.

Research Centre of the Institute of Cardiovascular Diseases, G. Adam Str. no 13A, 300310 Timișoara, Romania.

出版信息

Int J Mol Sci. 2024 Sep 25;25(19):10307. doi: 10.3390/ijms251910307.

DOI:10.3390/ijms251910307
PMID:39408637
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11477003/
Abstract

Monoamine oxidases (MAOs), mitochondrial enzymes that constantly produce hydrogen peroxide (HO) as a byproduct of their activity, have been recently acknowledged as contributors to oxidative stress in cardiometabolic pathologies. The present study aimed to assess whether MAOs are mediators of valvular oxidative stress and interact in vitro with angiotensin 2 (ANG2) to mimic the activation of the renin-angiotensin system. To this aim, valvular tissue samples were harvested from 30 patients diagnosed with severe primary mitral regurgitation and indication for surgical repair. Their reactive oxygen species (ROS) levels were assessed by means of a ferrous oxidation xylenol orange (FOX) assay, while MAO expression was assessed by immune fluorescence (protein) and qRT-PCR (mRNA). The experiments were performed using native valvular tissue acutely incubated or not with angiotensin 2 (ANG2), MAO inhibitors (MAOI) and the angiotensin receptor blocker, irbesartan (Irb). Correlations between oxidative stress and echocardiographic parameters were also analyzed. Ex vivo incubation with ANG2 increased MAO-A and -B expression and ROS generation. The level of valvular oxidative stress was negatively correlated with the left ventricular ejection fraction. MAOI and Irb reduced valvular HO production. In conclusion, both MAO isoforms are expressed in pathological human mitral valves and contribute to local oxidative stress and ventricular functional impairment and can be modulated by the local renin-angiotensin system

摘要

单胺氧化酶(MAO)是线粒体酶,其活性的副产物不断产生过氧化氢(HO),最近被认为是心脏代谢病理中氧化应激的贡献者。本研究旨在评估 MAO 是否是瓣膜氧化应激的介质,并在体外与血管紧张素 2(ANG2)相互作用以模拟肾素-血管紧张素系统的激活。为此,从 30 名被诊断为严重原发性二尖瓣反流并需要手术修复的患者中采集瓣膜组织样本。通过亚铁氧化邻甲氨基酚(FOX)测定法评估其活性氧(ROS)水平,通过免疫荧光(蛋白质)和 qRT-PCR(mRNA)评估 MAO 表达。使用天然瓣膜组织进行急性孵育或不孵育血管紧张素 2(ANG2)、MAO 抑制剂(MAOI)和血管紧张素受体阻滞剂厄贝沙坦(Irb)进行实验。还分析了氧化应激与超声心动图参数之间的相关性。体外孵育 ANG2 增加了 MAO-A 和 -B 的表达和 ROS 的产生。瓣膜氧化应激水平与左心室射血分数呈负相关。MAOI 和 Irb 减少了瓣膜 HO 的产生。总之,两种 MAO 同工酶都在病理性人二尖瓣中表达,并导致局部氧化应激和心室功能障碍,并且可以通过局部肾素-血管紧张素系统进行调节。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3412/11477003/c4cad2114ea1/ijms-25-10307-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3412/11477003/e06468aacd6d/ijms-25-10307-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3412/11477003/9918c3675a3c/ijms-25-10307-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3412/11477003/1f191da9cf13/ijms-25-10307-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3412/11477003/8783b8d2c404/ijms-25-10307-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3412/11477003/c4cad2114ea1/ijms-25-10307-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3412/11477003/e06468aacd6d/ijms-25-10307-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3412/11477003/9918c3675a3c/ijms-25-10307-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3412/11477003/1f191da9cf13/ijms-25-10307-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3412/11477003/8783b8d2c404/ijms-25-10307-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3412/11477003/c4cad2114ea1/ijms-25-10307-g005.jpg

相似文献

1
Monoamine Oxidase Contributes to Valvular Oxidative Stress: A Prospective Observational Pilot Study in Patients with Severe Mitral Regurgitation.单胺氧化酶导致瓣叶氧化应激:严重二尖瓣反流患者的前瞻性观察性初步研究。
Int J Mol Sci. 2024 Sep 25;25(19):10307. doi: 10.3390/ijms251910307.
2
Monoamine Oxidase (MAO) Is Expressed at the Level of Mitral Valve with Severe Regurgitation in Hypertrophic Obstructive Cardiomyopathy: A Case Report.肥厚型梗阻性心肌病伴严重反流的二尖瓣有单胺氧化酶(MAO)的表达:病例报告。
Medicina (Kaunas). 2022 Dec 15;58(12):1844. doi: 10.3390/medicina58121844.
3
Contribution of monoamine oxidases to vascular oxidative stress in patients with end-stage renal disease requiring hemodialysis.单胺氧化酶对需要血液透析的终末期肾病患者血管氧化应激的作用。
Can J Physiol Pharmacol. 2017 Nov;95(11):1383-1388. doi: 10.1139/cjpp-2017-0067. Epub 2017 Jul 28.
4
Monoamine oxidases are novel sources of cardiovascular oxidative stress in experimental diabetes.单胺氧化酶是实验性糖尿病中心血管氧化应激的新来源。
Can J Physiol Pharmacol. 2015 Jul;93(7):555-61. doi: 10.1139/cjpp-2014-0544. Epub 2015 Mar 12.
5
Monoamine Oxidase Inhibitors Prevent Glucose-Dependent Energy Production, Proliferation and Migration of Bladder Carcinoma Cells.单胺氧化酶抑制剂可阻止膀胱癌细胞的葡萄糖依赖性能量产生、增殖和迁移。
Int J Mol Sci. 2022 Oct 4;23(19):11747. doi: 10.3390/ijms231911747.
6
Monoamine oxidases are mediators of endothelial dysfunction in the mouse aorta.单胺氧化酶是小鼠主动脉内皮功能障碍的介导者。
Hypertension. 2013 Jul;62(1):140-6. doi: 10.1161/HYPERTENSIONAHA.113.01314. Epub 2013 May 13.
7
Assessment of Mitochondrial Dysfunction and Monoamine Oxidase Contribution to Oxidative Stress in Human Diabetic Hearts.评估线粒体功能障碍和单胺氧化酶对人类糖尿病心脏氧化应激的影响。
Oxid Med Cell Longev. 2016;2016:8470394. doi: 10.1155/2016/8470394. Epub 2016 Apr 13.
8
Metformin and empagliflozin modulate monoamine oxidase-related oxidative stress and improve vascular function in human mammary arteries.二甲双胍和恩格列净调节与单胺氧化酶相关的氧化应激,改善人乳动脉的血管功能。
Mol Cell Biochem. 2023 Sep;478(9):1939-1947. doi: 10.1007/s11010-022-04633-8. Epub 2022 Dec 30.
9
Empagliflozin and dapagliflozin decreased atrial monoamine oxidase expression and alleviated oxidative stress in overweight non-diabetic cardiac patients.恩格列净和达格列净降低超重非糖尿病心脏病患者心房单胺氧化酶表达并减轻氧化应激。
Mol Cell Biochem. 2025 Mar;480(3):1645-1655. doi: 10.1007/s11010-024-05076-z. Epub 2024 Jul 23.
10
Methylene blue reduces monoamine oxidase expression and oxidative stress in human cardiovascular adipose tissue.亚甲蓝可降低人体心血管脂肪组织中的单胺氧化酶表达及氧化应激水平。
Mol Cell Biochem. 2025 Apr;480(4):2413-2421. doi: 10.1007/s11010-024-05092-z. Epub 2024 Aug 21.

引用本文的文献

1
Vasculo-Protective Effects of Standardized Black Chokeberry Extracts in Mice Aorta.标准化黑接骨木提取物对小鼠主动脉的血管保护作用
Int J Mol Sci. 2024 Dec 17;25(24):13520. doi: 10.3390/ijms252413520.
2
Adipose tissue as target of environmental toxicants: focus on mitochondrial dysfunction and oxidative inflammation in metabolic dysfunction-associated steatotic liver disease.脂肪组织作为环境毒物的作用靶点:聚焦代谢功能障碍相关脂肪性肝病中的线粒体功能障碍和氧化炎症
Mol Cell Biochem. 2025 May;480(5):2863-2879. doi: 10.1007/s11010-024-05165-z. Epub 2024 Dec 20.

本文引用的文献

1
Progress in Understanding Oxidative Stress, Aging, and Aging-Related Diseases.氧化应激、衰老及衰老相关疾病的研究进展
Antioxidants (Basel). 2024 Mar 25;13(4):394. doi: 10.3390/antiox13040394.
2
Cardiac monoamine oxidase-A inhibition protects against catecholamine-induced ventricular arrhythmias via enhanced diastolic calcium control.心脏单胺氧化酶-A 抑制通过增强舒张期钙控制预防儿茶酚胺诱导的室性心律失常。
Cardiovasc Res. 2024 May 7;120(6):596-611. doi: 10.1093/cvr/cvae012.
3
Monoamine oxidase mediated oxidative stress: a potential molecular and biochemical crux in the pathogenesis of obesity.
单胺氧化酶介导的氧化应激:肥胖发病机制中的潜在分子和生化关键。
Mol Biol Rep. 2023 Dec 23;51(1):29. doi: 10.1007/s11033-023-08938-9.
4
Hyperuricemia and Its Association With the Severity and Complications of Congestive Heart Failure: A Systematic Review.高尿酸血症及其与充血性心力衰竭严重程度和并发症的关联:一项系统综述
Cureus. 2023 Sep 14;15(9):e45246. doi: 10.7759/cureus.45246. eCollection 2023 Sep.
5
Recent advances on the role of monoamine oxidases in cardiac pathophysiology.单胺氧化酶在心脏病理生理学中作用的最新进展
Basic Res Cardiol. 2023 Oct 4;118(1):41. doi: 10.1007/s00395-023-01012-2.
6
NADPH Oxidases: From Molecular Mechanisms to Current Inhibitors.NADPH 氧化酶:从分子机制到当前抑制剂。
J Med Chem. 2023 Sep 14;66(17):11632-11655. doi: 10.1021/acs.jmedchem.3c00770. Epub 2023 Aug 31.
7
Monoamine Oxidase A Contributes to Serotonin-But Not Norepinephrine-Dependent Damage of Rat Ventricular Myocytes.单胺氧化酶 A 导致大鼠心室肌细胞的 5-羟色胺依赖性损伤,但不导致去甲肾上腺素依赖性损伤。
Biomolecules. 2023 Jun 19;13(6):1013. doi: 10.3390/biom13061013.
8
Importance of Mitochondria in Cardiac Pathologies: Focus on Uncoupling Proteins and Monoamine Oxidases.线粒体在心脏病理学中的重要性:聚焦解偶联蛋白和单胺氧化酶。
Int J Mol Sci. 2023 Mar 30;24(7):6459. doi: 10.3390/ijms24076459.
9
The Global Burden of Valvular Heart Disease: From Clinical Epidemiology to Management.心脏瓣膜病的全球负担:从临床流行病学到管理
J Clin Med. 2023 Mar 10;12(6):2178. doi: 10.3390/jcm12062178.
10
Metformin and empagliflozin modulate monoamine oxidase-related oxidative stress and improve vascular function in human mammary arteries.二甲双胍和恩格列净调节与单胺氧化酶相关的氧化应激,改善人乳动脉的血管功能。
Mol Cell Biochem. 2023 Sep;478(9):1939-1947. doi: 10.1007/s11010-022-04633-8. Epub 2022 Dec 30.